(OMC) Omnicom - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6819191064
Stock:
Total Rating 24
Risk 60
Buy Signal 0.00
| Risk 5d forecast | |
|---|---|
| Volatility | 36.8% |
| Relative Tail Risk | -6.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.26 |
| Alpha | -6.59 |
| Character TTM | |
|---|---|
| Beta | 0.742 |
| Beta Downside | 0.736 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.29% |
| CAGR/Max DD | 0.03 |
EPS (Earnings per Share)
Revenue
Description: OMC Omnicom
Omnicom Group Inc., together with its subsidiaries, offers advertising, marketing, and corporate communications services. It provides a range of services in the areas of media and advertising, precision marketing, public relations, healthcare, branding and retail commerce, experiential, execution, and support. The company's services include advertising, branding, content marketing, crisis communications, customer data analytics and data-driven decision making, customer relationship management, decision sciences, digital experience design, digital transformation, e-commerce optimization, entertainment marketing, experiential marketing, field marketing, healthcare marketing and communications, in-store design, investor relations, and marketing research.Its services also comprise media planning and buying, merchandising and point of sale, mobile marketing, multi-cultural marketing, organizational communications, package design, performance marketing, product placement, promotional marketing, public affairs, public relations, retail media and e-commerce, shopper marketing, structured innovation, studio production, social media and influencer marketing, and sports and event marketing. It operates in the North and Latin America, Europe, the Middle East and Africa (EMEA), and the Asia Pacific. The company was incorporated in 1944 and is based in New York, New York.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -54.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.25 > 1.0 |
| NWC/Revenue: -12.00% < 20% (prev -0.49%; Δ -11.51% < -1%) |
| CFO/TA 0.05 > 3% & CFO 2.94b > Net Income -54.5m |
| Net Debt (5.90b) to EBITDA (825.3m): 7.15 < 3 |
| Current Ratio: 0.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (233.8m) vs 12m ago 17.84% < -2% |
| Gross Margin: 17.28% > 18% (prev 0.17%; Δ 1710 % > 0.5%) |
| Asset Turnover: 41.11% > 50% (prev 52.97%; Δ -11.86% > 0%) |
| Interest Coverage Ratio: 2.08 > 6 (EBITDA TTM 825.3m / Interest Expense TTM 263.4m) |
Altman Z'' 0.73
| A: -0.04 (Total Current Assets 27.47b - Total Current Liabilities 29.54b) / Total Assets 54.42b |
| B: 0.20 (Retained Earnings 10.78b / Total Assets 54.42b) |
| C: 0.01 (EBIT TTM 548.6m / Avg Total Assets 42.02b) |
| D: 0.23 (Book Value of Equity 9.58b / Total Liabilities 41.36b) |
| Altman-Z'' Score: 0.73 = B |
Beneish M -2.29
| DSRI: 1.75 (Receivables 17.81b/9.24b, Revenue 17.27b/15.69b) |
| GMI: 1.01 (GM 17.28% / 17.47%) |
| AQI: 1.16 (AQ_t 0.45 / AQ_t-1 0.39) |
| SGI: 1.10 (Revenue 17.27b / 15.69b) |
| TATA: -0.05 (NI -54.5m - CFO 2.94b) / TA 54.42b) |
| Beneish M-Score: -2.29 (Cap -4..+1) = BBB |
What is the price of OMC shares?
As of March 03, 2026, the stock is trading at USD 85.36 with a total of 3,388,776 shares traded.
Over the past week, the price has changed by +5.71%, over one month by +11.55%, over three months by +18.95% and over the past year by +9.75%.
Over the past week, the price has changed by +5.71%, over one month by +11.55%, over three months by +18.95% and over the past year by +9.75%.
Is OMC a buy, sell or hold?
Omnicom has received a consensus analysts rating of 3.91.
Therefore, it is recommended to buy OMC.
- StrongBuy: 3
- Buy: 5
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the OMC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 100.5 | 17.7% |
| Analysts Target Price | 100.5 | 17.7% |
OMC Fundamental Data Overview February 27, 2026
P/E Forward = 8.3542
P/S = 1.5065
P/B = 3.3181
P/EG = 1.223
Revenue TTM = 17.27b USD
EBIT TTM = 548.6m USD
EBITDA TTM = 825.3m USD
Long Term Debt = 4.88b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.89b USD (from shortTermDebt, last quarter)
Debt = 12.78b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.90b USD (from netDebt column, last quarter)
Enterprise Value = 31.92b USD (26.02b + Debt 12.78b - CCE 6.88b)
Interest Coverage Ratio = 2.08 (Ebit TTM 548.6m / Interest Expense TTM 263.4m)
EV/FCF = 11.45x (Enterprise Value 31.92b / FCF TTM 2.79b)
FCF Yield = 8.74% (FCF TTM 2.79b / Enterprise Value 31.92b)
FCF Margin = 16.14% (FCF TTM 2.79b / Revenue TTM 17.27b)
Net Margin = -0.32% (Net Income TTM -54.5m / Revenue TTM 17.27b)
Gross Margin = 17.28% ((Revenue TTM 17.27b - Cost of Revenue TTM 14.29b) / Revenue TTM)
Gross Margin QoQ = 17.79% (prev 18.14%)
Tobins Q-Ratio = 0.59 (Enterprise Value 31.92b / Total Assets 54.42b)
Interest Expense / Debt = 0.64% (Interest Expense 81.3m / Debt 12.78b)
Taxrate = 21.0% (US default 21%)
NOPAT = 433.4m (EBIT 548.6m * (1 - 21.00%))
Current Ratio = 0.93 (Total Current Assets 27.47b / Total Current Liabilities 29.54b)
Debt / Equity = 1.06 (Debt 12.78b / totalStockholderEquity, last quarter 12.05b)
Debt / EBITDA = 7.15 (Net Debt 5.90b / EBITDA 825.3m)
Debt / FCF = 2.12 (Net Debt 5.90b / FCF TTM 2.79b)
Total Stockholder Equity = 6.38b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.13% (Net Income -54.5m / Total Assets 54.42b)
RoE = -0.85% (Net Income TTM -54.5m / Total Stockholder Equity 6.38b)
RoCE = 4.87% (EBIT 548.6m / Capital Employed (Equity 6.38b + L.T.Debt 4.88b))
RoIC = 4.04% (NOPAT 433.4m / Invested Capital 10.74b)
WACC = 5.97% (E(26.02b)/V(38.80b) * Re(8.65%) + D(12.78b)/V(38.80b) * Rd(0.64%) * (1-Tc(0.21)))
Discount Rate = 8.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 8.26%
[DCF] Terminal Value 88.19% ; FCFF base≈2.31b ; Y1≈2.85b ; Y5≈4.85b
[DCF] Fair Price = 425.8 (EV 138.03b - Net Debt 5.90b = Equity 132.13b / Shares 310.3m; r=5.97% [WACC]; 5y FCF grow 24.94% → 2.90% )
EPS Correlation: 68.42 | EPS CAGR: 18.05% | SUE: -0.82 | # QB: 0
Revenue Correlation: 72.21 | Revenue CAGR: 13.75% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.77 | Chg7d=+0.350 | Chg30d=+0.363 | Revisions Net=+3 | Analysts=5
EPS current Year (2026-12-31): EPS=11.14 | Chg7d=+1.179 | Chg30d=+1.206 | Revisions Net=+1 | Growth EPS=+28.7% | Growth Revenue=+46.2%
EPS next Year (2027-12-31): EPS=12.75 | Chg7d=+1.127 | Chg30d=+1.162 | Revisions Net=+2 | Growth EPS=+14.5% | Growth Revenue=+2.0%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
P/S = 1.5065
P/B = 3.3181
P/EG = 1.223
Revenue TTM = 17.27b USD
EBIT TTM = 548.6m USD
EBITDA TTM = 825.3m USD
Long Term Debt = 4.88b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.89b USD (from shortTermDebt, last quarter)
Debt = 12.78b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.90b USD (from netDebt column, last quarter)
Enterprise Value = 31.92b USD (26.02b + Debt 12.78b - CCE 6.88b)
Interest Coverage Ratio = 2.08 (Ebit TTM 548.6m / Interest Expense TTM 263.4m)
EV/FCF = 11.45x (Enterprise Value 31.92b / FCF TTM 2.79b)
FCF Yield = 8.74% (FCF TTM 2.79b / Enterprise Value 31.92b)
FCF Margin = 16.14% (FCF TTM 2.79b / Revenue TTM 17.27b)
Net Margin = -0.32% (Net Income TTM -54.5m / Revenue TTM 17.27b)
Gross Margin = 17.28% ((Revenue TTM 17.27b - Cost of Revenue TTM 14.29b) / Revenue TTM)
Gross Margin QoQ = 17.79% (prev 18.14%)
Tobins Q-Ratio = 0.59 (Enterprise Value 31.92b / Total Assets 54.42b)
Interest Expense / Debt = 0.64% (Interest Expense 81.3m / Debt 12.78b)
Taxrate = 21.0% (US default 21%)
NOPAT = 433.4m (EBIT 548.6m * (1 - 21.00%))
Current Ratio = 0.93 (Total Current Assets 27.47b / Total Current Liabilities 29.54b)
Debt / Equity = 1.06 (Debt 12.78b / totalStockholderEquity, last quarter 12.05b)
Debt / EBITDA = 7.15 (Net Debt 5.90b / EBITDA 825.3m)
Debt / FCF = 2.12 (Net Debt 5.90b / FCF TTM 2.79b)
Total Stockholder Equity = 6.38b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.13% (Net Income -54.5m / Total Assets 54.42b)
RoE = -0.85% (Net Income TTM -54.5m / Total Stockholder Equity 6.38b)
RoCE = 4.87% (EBIT 548.6m / Capital Employed (Equity 6.38b + L.T.Debt 4.88b))
RoIC = 4.04% (NOPAT 433.4m / Invested Capital 10.74b)
WACC = 5.97% (E(26.02b)/V(38.80b) * Re(8.65%) + D(12.78b)/V(38.80b) * Rd(0.64%) * (1-Tc(0.21)))
Discount Rate = 8.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 8.26%
[DCF] Terminal Value 88.19% ; FCFF base≈2.31b ; Y1≈2.85b ; Y5≈4.85b
[DCF] Fair Price = 425.8 (EV 138.03b - Net Debt 5.90b = Equity 132.13b / Shares 310.3m; r=5.97% [WACC]; 5y FCF grow 24.94% → 2.90% )
EPS Correlation: 68.42 | EPS CAGR: 18.05% | SUE: -0.82 | # QB: 0
Revenue Correlation: 72.21 | Revenue CAGR: 13.75% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.77 | Chg7d=+0.350 | Chg30d=+0.363 | Revisions Net=+3 | Analysts=5
EPS current Year (2026-12-31): EPS=11.14 | Chg7d=+1.179 | Chg30d=+1.206 | Revisions Net=+1 | Growth EPS=+28.7% | Growth Revenue=+46.2%
EPS next Year (2027-12-31): EPS=12.75 | Chg7d=+1.127 | Chg30d=+1.162 | Revisions Net=+2 | Growth EPS=+14.5% | Growth Revenue=+2.0%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)